LexisNexis Risk Solutions to Discuss Social Determinants of Health at Pharmacy Quality Alliance Panel Discussion
Conference panel will focus on the role of SDOH in risk adjustment
Nov 14, 2018, 16:29 ET
ATLANTA, Nov. 14, 2018 /PRNewswire/ -- LexisNexis® Risk Solutions, a pioneer in the social determinants of health (SDOH) arena will participate in a key thought-leader panel discussion, "Beyond Risk Adjustment: The Role of Quality Measurement in Improving Access and Reducing Disparities," Nov. 15 at the Pharmacy Quality Alliance (PQA) Social Determinants of Health Forum: Exploring Medication Access and Quality, in Alexandria, Virginia. LexisNexis has been collaborating with the PQA for nearly two years to highlight the impact social determinants of health (SDOH) have on patient health outcomes.
The panel will feature experts from across the healthcare industry, who will speak to important considerations such as:
- the impact of social determinants on quality;
- the utility of risk adjustment within quality measurement;
- how patient-centric measure development can impact health disparities; and
- how quality measures can improve healthcare access and equity.
Erin Benson, director of Market Planning at LexisNexis Risk Solutions, will share remarks that highlight how social determinants of health improve the industry's ability to improve patient care by offering a lens into risks unseen.
"Insights gained from social determinants of health scores and other predictive models give pharmacists and providers a more holistic view of their patients," Benson said. "They can make better-informed decisions and be proactive in performing consultations and prescribing treatment that will work well within a patient's dynamic life. They can also encourage patient engagement in improving health outcomes."
"When talking about social determinants of health, there still is a lot of education that needs to happen across the industry," said Josh Schoeller, senior vice president and general manager, Health Care, LexisNexis Risk Solutions. "There tends to be general agreement that data analytics can help achieve better treatment outcomes, help reduce readmissions and help improve medication adherence – and social determinants are critical ingredients to realizing this. Social determinants of health and the innovative data analytics that support their effectiveness are playing a key role in the care of patients."
Dr. David Nash, professor of Health Policy, and Dean of the Jefferson College of Population Health, will moderate the panel. Benson's fellow panelists will include:
- Keri Christensen, director, Research Innovation, National Committee for Quality Assurance
- Eric Gascho, vice president, Policy and Government Affairs, National Health Council
- Lynn Pezzullo, RPh, senior director, Quality Innovation, Pharmacy Quality Alliance
The panel is scheduled to begin at 11 a.m. ET. Members of the media can arrange to speak with Ms. Benson through the LexisNexis contact below.
About LexisNexis Risk Solutions
LexisNexis® Risk Solutions harnesses the power of data and advanced analytics to provide insights that help businesses and governmental entities reduce risk and improve decisions to benefit people around the globe. We provide data and technology solutions for a wide range of industries including insurance, financial services, healthcare and government. Headquartered in metro Atlanta, Georgia, we have offices throughout the world and are part of RELX Group (LSE: REL/NYSE: RELX), a global provider of information and analytics for professional and business customers across industries. For more information, please visit www.risk.lexisnexis.com, and www.relx.com.
SOURCE LexisNexis Risk Solutions
